Target intelligence / Profile preview

Potassium channel protein in dental nerve fibers (null)

Target
null
Molecular classification
Ion channel, Voltage-gated potassium channel, Calcium-activated potassium channel, Inwardly rectifying potassium channel, Two-pore domain potassium channel
01

Overview

Potassium channels in dental nerve fibers are diverse membrane-spanning proteins that selectively permit the flow of potassium ions (K⁺), thereby regulating nerve fiber excitability, signal conduction, and the repolarization of action potentials. These channels—encompassing voltage-gated (KV), calcium-activated (KCa), inwardly rectifying (Kir), and two-pore domain (K2P) subtypes—are fundamentally involved in setting the electrical properties of the nerves in the dental pulp, and play critical roles in mediating pain, sensitivity, and overall nerve function in oral tissues[1][5]. Their activity modifies resting membrane potential and action potential dynamics, impacting the perception of pain and the effectiveness of local anesthetic agents[3].

Other names
Potassium ion channelVoltage-gated potassium channel (KV)Calcium-activated potassium channel (KCa)Inwardly rectifying potassium channel (Kir)Two-pore domain potassium channel (K2P)
02

Mechanism of action

Drugs may block or enhance potassium conductance, thereby altering nerve excitability and pain transmission. Blockers delay repolarization, enhancing nerve activity, while openers increase potassium efflux, reducing excitability and pain signaling[1][5].

03

Biological functions

Regulation of action potential and its repolarizationResting membrane potential maintenanceControl of neuronal excitabilityHyperpolarization and after-hyperpolarizationModulation of sensory transmission (nociception/pain)Potassium homeostasis
04

Disease associations

Inflammation (pulpitis/dental pain)Neuropathic pain/sensory hypersensitivityOther pain disorders
05

Safety considerations

Possible impact on normal neuronal function if potassium channels are broadly inhibited or excessively activated (risk of nerve hypoactivity, arrhythmias, or non-specific side effects)Potential decrease in local anesthesia effectiveness (if altered potassium channel expression), presenting a therapeutic challenge during dental procedures
06

Interacting drugs

Local anesthetics

4 more in the full profile.

07

Biomarkers

Upregulation or expression profiling of potassium channel subunits in dental nerve fibers (for example, immunohistochemistry or mRNA analyses assessing presence/activity of KV1.4, KCa, etc. in pain conditions)

Beyond the preview

Go deeper on Potassium channel protein in dental nerve fibers (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium channel protein in dental nerve fibers (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call